BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 28849684)

  • 1. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
    Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
    Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer.
    Ramlov A; Assenholt MS; Jensen MF; Grønborg C; Nout R; Alber M; Fokdal L; Tanderup K; Lindegaard JC
    Radiother Oncol; 2017 Apr; 123(1):158-163. PubMed ID: 28190601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
    Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC
    Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coverage probability planning for simultaneously integrated boosts of inguinal lymph nodes in vulvar cancer.
    Mohamed S; Assenholt MS; Fokdal L; Kallehauge J; Lindegaard JC; Tanderup K
    Acta Oncol; 2022 Nov; 61(11):1406-1411. PubMed ID: 36369704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less Than Whole Uterus Irradiation for Locally Advanced Cervical Cancer Maintains Locoregional Control and Decreases Radiation Dose to Bowel.
    Kozak MM; Koenig JL; von Eyben R; Kidd EA
    Pract Radiat Oncol; 2019 Mar; 9(2):e164-e171. PubMed ID: 30395974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose simultaneous integrated boost for node positive cervical cancer.
    Jayatilakebanda I; Tsang YM; Hoskin P
    Radiat Oncol; 2021 May; 16(1):92. PubMed ID: 34001158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of simultaneous integrated boost and sequential boost radiotherapy in node-positive cervical cancer: dosimetric and radiobiological considerations.
    Mishra R; Singh S; Patel G; Mandal A; Mishra H; Pandey A; Bahadur B; Singh PK; Sachan S; Tewari M
    Radiat Environ Biophys; 2024 May; 63(2):297-306. PubMed ID: 38722389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of image-guided adaptive brachytherapy to pelvic nodes treatment in locally advanced cervical cancer.
    Bacorro W; Dumas I; Levy A; Rivin Del Campo E; Canova CH; Felefly T; Huertas A; Marsolat F; Haie-Meder C; Chargari C; Mazeron R
    Brachytherapy; 2017; 16(2):366-372. PubMed ID: 28159552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
    Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
    Bacorro W; Dumas I; Escande A; Gouy S; Bentivegna E; Morice P; Haie-Meder C; Chargari C
    Gynecol Oncol; 2018 Mar; 148(3):461-467. PubMed ID: 29325690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of Technique, Target Selection, Contouring, Dose Prescription, and Dose-Planning in External Beam Radiation Therapy for Cervical Cancer: Evolution of Practice From EMBRACE-I to II.
    Berger T; Seppenwoolde Y; Pötter R; Assenholt MS; Lindegaard JC; Nout RA; de Leeuw A; Jürgenliemk-Schulz I; Tan LT; Georg D; Kirisits C; Dumas I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Fokdal L; Tanderup K;
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):885-894. PubMed ID: 30904706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
    Snyder JE; Willett AB; Sun W; Kim Y
    Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort.
    Nomden CN; Pötter R; de Leeuw AAC; Tanderup K; Lindegaard JC; Schmid MP; Fortin I; Haie-Meder C; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Huang F; Cooper R; Van Der Steen Banasik E; Van Limbergen E; Jürgenliemk-Schulz IM;
    Radiother Oncol; 2019 May; 134():185-190. PubMed ID: 31005214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMRT with ¹⁸FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
    Cihoric N; Tapia C; Krüger K; Aebersold DM; Klaeser B; Lössl K
    Radiat Oncol; 2014 Mar; 9():83. PubMed ID: 24661323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation.
    Vandecasteele K; De Neve W; De Gersem W; Delrue L; Paelinck L; Makar A; Fonteyne V; De Wagter C; Villeirs G; De Meerleer G
    Strahlenther Onkol; 2009 Dec; 185(12):799-807. PubMed ID: 20013089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.